An examination of data of people who received the Pfizer-BioNTech COVID-19 vaccine in Israel found males 14 to 30 years of age were the most susceptible to myocarditis after a second or third dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results